Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS1
|
ENSG00000143995.15 | Meis homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_66722520_66722671 | MEIS1 | 13464 | 0.215060 | 0.93 | 2.9e-04 | Click! |
chr2_66708251_66708455 | MEIS1 | 27706 | 0.163111 | 0.89 | 1.4e-03 | Click! |
chr2_66708649_66708800 | MEIS1 | 27335 | 0.164465 | 0.88 | 1.6e-03 | Click! |
chr2_67093990_67094141 | MEIS1 | 358006 | 0.009180 | 0.88 | 2.0e-03 | Click! |
chr2_66723693_66723844 | MEIS1 | 12291 | 0.219387 | 0.86 | 3.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr20_10286775_10287859 | 1.59 |
ENSG00000211588 |
. |
55561 |
0.13 |
chr16_640639_641593 | 1.33 |
RAB40C |
RAB40C, member RAS oncogene family |
784 |
0.37 |
chr6_2103859_2104525 | 1.16 |
GMDS |
GDP-mannose 4,6-dehydratase |
72033 |
0.13 |
chr17_42872109_42872587 | 1.07 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
9986 |
0.14 |
chr8_49322257_49322678 | 0.87 |
ENSG00000252710 |
. |
101877 |
0.08 |
chr5_64493902_64494516 | 0.85 |
ENSG00000207439 |
. |
75013 |
0.12 |
chr9_124706762_124707039 | 0.84 |
RP11-244O19.1 |
|
125169 |
0.05 |
chr5_54896290_54897472 | 0.84 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
66003 |
0.11 |
chr5_134727254_134728171 | 0.83 |
H2AFY |
H2A histone family, member Y |
7189 |
0.17 |
chr5_37832382_37832533 | 0.82 |
GDNF |
glial cell derived neurotrophic factor |
2553 |
0.35 |
chr2_102352562_102353743 | 0.82 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
38160 |
0.21 |
chr2_36678756_36679028 | 0.80 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
61941 |
0.12 |
chr1_85755499_85756121 | 0.77 |
ENSG00000264380 |
. |
5517 |
0.15 |
chr17_76330977_76331356 | 0.76 |
SOCS3 |
suppressor of cytokine signaling 3 |
24989 |
0.13 |
chr2_224590547_224590825 | 0.75 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
111515 |
0.07 |
chr8_97603049_97603490 | 0.74 |
SDC2 |
syndecan 2 |
4654 |
0.31 |
chr3_50195246_50195978 | 0.74 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
840 |
0.45 |
chr14_78668483_78668908 | 0.73 |
ENSG00000199454 |
. |
24431 |
0.22 |
chr10_131821141_131821577 | 0.71 |
EBF3 |
early B-cell factor 3 |
59254 |
0.15 |
chr3_125230252_125231290 | 0.70 |
ENSG00000201800 |
. |
5052 |
0.18 |
chr11_60906509_60907112 | 0.70 |
VPS37C |
vacuolar protein sorting 37 homolog C (S. cerevisiae) |
21798 |
0.14 |
chr2_169385393_169385803 | 0.70 |
ENSG00000265694 |
. |
53855 |
0.12 |
chr12_88728604_88728755 | 0.69 |
ENSG00000199245 |
. |
95540 |
0.09 |
chr19_8017646_8018209 | 0.69 |
CTD-3193O13.14 |
|
6080 |
0.08 |
chr3_156817192_156817343 | 0.69 |
ENSG00000201778 |
. |
54070 |
0.11 |
chr1_94791983_94792377 | 0.69 |
ARHGAP29 |
Rho GTPase activating protein 29 |
88991 |
0.08 |
chr2_190647077_190647900 | 0.69 |
ORMDL1 |
ORM1-like 1 (S. cerevisiae) |
620 |
0.54 |
chr2_192732011_192732230 | 0.68 |
SDPR |
serum deprivation response |
20139 |
0.21 |
chr2_196440572_196441282 | 0.67 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
226 |
0.96 |
chr17_60074998_60075962 | 0.67 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr15_76068581_76068844 | 0.66 |
RP11-24M17.5 |
|
777 |
0.48 |
chr7_134200953_134201104 | 0.65 |
AKR1B10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
11316 |
0.22 |
chr12_95597054_95597379 | 0.64 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
13939 |
0.18 |
chr10_95197392_95197711 | 0.64 |
MYOF |
myoferlin |
44400 |
0.14 |
chr1_94018188_94018555 | 0.63 |
FNBP1L |
formin binding protein 1-like |
23104 |
0.17 |
chr10_80916996_80917718 | 0.62 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
88565 |
0.09 |
chr9_110610495_110610963 | 0.62 |
ENSG00000244104 |
. |
36534 |
0.17 |
chr9_117715769_117716310 | 0.62 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
23342 |
0.24 |
chr9_130308458_130308879 | 0.62 |
FAM129B |
family with sequence similarity 129, member B |
22699 |
0.15 |
chr1_117908214_117909192 | 0.62 |
MAN1A2 |
mannosidase, alpha, class 1A, member 2 |
1368 |
0.58 |
chr17_74734284_74735284 | 0.62 |
MFSD11 |
major facilitator superfamily domain containing 11 |
631 |
0.43 |
chr7_92393722_92393991 | 0.61 |
ENSG00000206763 |
. |
62728 |
0.11 |
chr7_134574979_134575413 | 0.61 |
CALD1 |
caldesmon 1 |
955 |
0.69 |
chr16_54482153_54482558 | 0.61 |
ENSG00000264079 |
. |
100953 |
0.08 |
chr4_111013284_111013435 | 0.60 |
ENSG00000263940 |
. |
25533 |
0.22 |
chr1_67037761_67038047 | 0.60 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
37939 |
0.17 |
chr1_78005634_78006073 | 0.59 |
AK5 |
adenylate kinase 5 |
8061 |
0.24 |
chr2_65605561_65605712 | 0.59 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
752 |
0.66 |
chr4_139328564_139328761 | 0.59 |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
165159 |
0.04 |
chr10_3791986_3792257 | 0.59 |
RP11-184A2.3 |
|
1138 |
0.55 |
chr2_169386523_169386797 | 0.59 |
ENSG00000265694 |
. |
52793 |
0.12 |
chr10_75648452_75648664 | 0.59 |
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma |
14215 |
0.12 |
chr3_45592432_45592722 | 0.59 |
ENSG00000251927 |
. |
41170 |
0.13 |
chr11_34449252_34449782 | 0.58 |
CAT |
catalase |
10955 |
0.23 |
chr8_118952354_118952505 | 0.57 |
EXT1 |
exostosin glycosyltransferase 1 |
170224 |
0.04 |
chr11_10922381_10922532 | 0.57 |
ZBED5-AS1 |
ZBED5 antisense RNA 1 |
35648 |
0.15 |
chr17_48718114_48718630 | 0.57 |
ABCC3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
6154 |
0.13 |
chr10_182306_183031 | 0.56 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
1219 |
0.53 |
chr13_44811098_44811768 | 0.56 |
SMIM2 |
small integral membrane protein 2 |
76040 |
0.1 |
chr1_66955749_66956137 | 0.56 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
43123 |
0.18 |
chr3_177209282_177209658 | 0.56 |
ENSG00000252028 |
. |
11870 |
0.31 |
chr3_192535060_192535352 | 0.56 |
FGF12 |
fibroblast growth factor 12 |
49653 |
0.16 |
chr5_77887462_77888069 | 0.56 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
42791 |
0.21 |
chr5_176972744_176973255 | 0.56 |
FAM193B |
family with sequence similarity 193, member B |
6647 |
0.12 |
chr7_115994446_115994930 | 0.55 |
ENSG00000216076 |
. |
8690 |
0.21 |
chr11_73126402_73126822 | 0.55 |
RP11-809N8.4 |
|
10270 |
0.16 |
chr3_183563662_183564003 | 0.55 |
PARL |
presenilin associated, rhomboid-like |
1770 |
0.27 |
chr16_69418220_69419135 | 0.55 |
TERF2 |
telomeric repeat binding factor 2 |
27 |
0.96 |
chr1_27868563_27868910 | 0.55 |
RP1-159A19.4 |
|
16420 |
0.16 |
chr1_27864005_27864199 | 0.54 |
RP1-159A19.4 |
|
11786 |
0.17 |
chr13_110492530_110492868 | 0.54 |
IRS2 |
insulin receptor substrate 2 |
53784 |
0.15 |
chr12_76982948_76983334 | 0.54 |
OSBPL8 |
oxysterol binding protein-like 8 |
29552 |
0.25 |
chr14_68206256_68206407 | 0.54 |
ENSG00000252792 |
. |
5860 |
0.12 |
chr7_33972018_33972169 | 0.54 |
BMPER |
BMP binding endothelial regulator |
26948 |
0.26 |
chr3_149291004_149291431 | 0.54 |
WWTR1 |
WW domain containing transcription regulator 1 |
2822 |
0.29 |
chr11_43708702_43708966 | 0.53 |
HSD17B12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
6503 |
0.28 |
chr5_52103796_52104046 | 0.53 |
CTD-2288O8.1 |
|
20061 |
0.18 |
chr1_183009603_183009956 | 0.53 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
17184 |
0.19 |
chr19_13112420_13112571 | 0.53 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
5843 |
0.1 |
chr5_139039554_139039936 | 0.53 |
CXXC5 |
CXXC finger protein 5 |
605 |
0.77 |
chr9_84174156_84174449 | 0.53 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
54135 |
0.17 |
chr15_40622287_40622525 | 0.53 |
ENSG00000252714 |
. |
1443 |
0.2 |
chr1_7531258_7531628 | 0.53 |
RP4-549F15.1 |
|
29829 |
0.21 |
chr18_434239_434644 | 0.53 |
RP11-720L2.2 |
|
10025 |
0.23 |
chr18_46188259_46188667 | 0.53 |
ENSG00000266276 |
. |
8508 |
0.24 |
chr7_98717947_98718887 | 0.53 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
23225 |
0.2 |
chr7_22602691_22603573 | 0.52 |
AC002480.3 |
|
176 |
0.96 |
chr1_29523867_29524018 | 0.52 |
SRSF4 |
serine/arginine-rich splicing factor 4 |
15443 |
0.14 |
chr2_236079152_236079303 | 0.52 |
ENSG00000216002 |
. |
155775 |
0.04 |
chr6_56595243_56595540 | 0.52 |
DST |
dystonin |
55286 |
0.16 |
chr7_47641377_47641730 | 0.52 |
TNS3 |
tensin 3 |
19397 |
0.24 |
chr7_27718120_27718271 | 0.52 |
HIBADH |
3-hydroxyisobutyrate dehydrogenase |
15581 |
0.23 |
chr7_30208402_30208666 | 0.52 |
AC007036.5 |
|
11387 |
0.17 |
chr11_35310584_35310759 | 0.52 |
RP1-68D18.3 |
|
7311 |
0.19 |
chr11_65075775_65076171 | 0.52 |
CDC42EP2 |
CDC42 effector protein (Rho GTPase binding) 2 |
6316 |
0.13 |
chr17_1686320_1687263 | 0.52 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
11778 |
0.11 |
chr18_60118556_60118821 | 0.51 |
ZCCHC2 |
zinc finger, CCHC domain containing 2 |
71552 |
0.1 |
chr9_38025689_38026106 | 0.51 |
SHB |
Src homology 2 domain containing adaptor protein B |
43311 |
0.16 |
chr15_40620685_40621172 | 0.51 |
ENSG00000252714 |
. |
2921 |
0.11 |
chr10_75346559_75346987 | 0.51 |
USP54 |
ubiquitin specific peptidase 54 |
4323 |
0.16 |
chr5_171380911_171381062 | 0.51 |
FBXW11 |
F-box and WD repeat domain containing 11 |
23774 |
0.23 |
chr14_93503097_93503248 | 0.51 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
29531 |
0.17 |
chr8_32084187_32084338 | 0.51 |
NRG1-IT2 |
NRG1 intronic transcript 2 (non-protein coding) |
5818 |
0.23 |
chr4_40623166_40623743 | 0.51 |
RBM47 |
RNA binding motif protein 47 |
8427 |
0.27 |
chr5_14210766_14211222 | 0.51 |
TRIO |
trio Rho guanine nucleotide exchange factor |
27087 |
0.27 |
chr15_100051927_100052783 | 0.51 |
AC015660.1 |
HCG1993240; Serologically defined breast cancer antigen NY-BR-40; Uncharacterized protein |
13777 |
0.21 |
chr1_207198601_207198841 | 0.51 |
C1orf116 |
chromosome 1 open reading frame 116 |
7371 |
0.14 |
chr6_75320101_75320588 | 0.51 |
ENSG00000264884 |
. |
109215 |
0.08 |
chr1_222005610_222005904 | 0.51 |
ENSG00000200033 |
. |
5022 |
0.33 |
chr17_17349796_17350202 | 0.50 |
ENSG00000201741 |
. |
13759 |
0.16 |
chr3_159646010_159646245 | 0.50 |
IL12A |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
60410 |
0.11 |
chr21_43084705_43084867 | 0.50 |
LINC00112 |
long intergenic non-protein coding RNA 112 |
51810 |
0.12 |
chr2_158695609_158696251 | 0.50 |
ACVR1 |
activin A receptor, type I |
1091 |
0.53 |
chr4_170192796_170193656 | 0.50 |
SH3RF1 |
SH3 domain containing ring finger 1 |
970 |
0.68 |
chr6_16681395_16681795 | 0.50 |
RP1-151F17.1 |
|
79774 |
0.1 |
chr17_74542991_74543547 | 0.50 |
RP11-666A8.7 |
|
2764 |
0.11 |
chr11_14380858_14381307 | 0.50 |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
352 |
0.92 |
chr1_29528780_29529144 | 0.50 |
SRSF4 |
serine/arginine-rich splicing factor 4 |
20463 |
0.13 |
chr5_36444408_36444559 | 0.50 |
ENSG00000222178 |
. |
40962 |
0.19 |
chr3_128914264_128914631 | 0.50 |
CNBP |
CCHC-type zinc finger, nucleic acid binding protein |
11682 |
0.14 |
chr6_44032625_44032924 | 0.50 |
RP5-1120P11.1 |
|
9615 |
0.18 |
chr5_73497876_73498136 | 0.50 |
ENSG00000222551 |
. |
69584 |
0.13 |
chr3_30537171_30537700 | 0.50 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
110559 |
0.07 |
chr1_109740426_109740857 | 0.50 |
ENSG00000238310 |
. |
9829 |
0.15 |
chr10_12749931_12750325 | 0.50 |
ENSG00000221331 |
. |
17224 |
0.27 |
chr10_127897548_127897699 | 0.50 |
ENSG00000222740 |
. |
63472 |
0.14 |
chr2_17918691_17918975 | 0.49 |
SMC6 |
structural maintenance of chromosomes 6 |
16207 |
0.21 |
chr17_6494499_6494650 | 0.49 |
KIAA0753 |
KIAA0753 |
3745 |
0.16 |
chr20_4141763_4142358 | 0.49 |
SMOX |
spermine oxidase |
10297 |
0.21 |
chr11_111425640_111425791 | 0.49 |
LAYN |
layilin |
13438 |
0.12 |
chr1_224752371_224752739 | 0.49 |
RP11-100E13.1 |
|
51367 |
0.13 |
chr2_12959099_12960371 | 0.49 |
ENSG00000264370 |
. |
82242 |
0.11 |
chr4_55408709_55408988 | 0.49 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
115237 |
0.07 |
chr5_146816614_146816990 | 0.48 |
DPYSL3 |
dihydropyrimidinase-like 3 |
16449 |
0.24 |
chr10_12746629_12746780 | 0.48 |
ENSG00000221331 |
. |
20648 |
0.26 |
chr17_33391534_33391907 | 0.48 |
RFFL |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
849 |
0.46 |
chr11_19222231_19222783 | 0.48 |
CSRP3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
1082 |
0.5 |
chr6_35568601_35569436 | 0.48 |
ENSG00000212579 |
. |
50577 |
0.1 |
chr19_44324236_44324553 | 0.48 |
LYPD5 |
LY6/PLAUR domain containing 5 |
356 |
0.82 |
chr8_131248547_131249235 | 0.48 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
10397 |
0.28 |
chr18_59659781_59660176 | 0.48 |
RNF152 |
ring finger protein 152 |
98514 |
0.08 |
chr21_44614410_44614785 | 0.48 |
CRYAA |
crystallin, alpha A |
24331 |
0.16 |
chr17_29648735_29649257 | 0.48 |
EVI2A |
ecotropic viral integration site 2A |
94 |
0.95 |
chr1_17559878_17560367 | 0.48 |
PADI1 |
peptidyl arginine deiminase, type I |
272 |
0.9 |
chr9_94533727_94534271 | 0.48 |
ENSG00000266855 |
. |
135466 |
0.05 |
chr6_17993158_17993663 | 0.48 |
KIF13A |
kinesin family member 13A |
5556 |
0.3 |
chr12_80325699_80326566 | 0.48 |
PPP1R12A |
protein phosphatase 1, regulatory subunit 12A |
2363 |
0.27 |
chr12_63119634_63119853 | 0.48 |
ENSG00000238475 |
. |
74788 |
0.09 |
chr2_12459909_12460205 | 0.47 |
ENSG00000207183 |
. |
91570 |
0.09 |
chr7_47676175_47676459 | 0.47 |
C7orf65 |
chromosome 7 open reading frame 65 |
18525 |
0.24 |
chr3_134044981_134045468 | 0.47 |
AMOTL2 |
angiomotin like 2 |
45530 |
0.15 |
chr5_124895396_124895838 | 0.47 |
ENSG00000222107 |
. |
208793 |
0.03 |
chr11_57542945_57543611 | 0.47 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
5797 |
0.16 |
chr6_129966569_129967050 | 0.47 |
ARHGAP18 |
Rho GTPase activating protein 18 |
64561 |
0.13 |
chr12_14413818_14414239 | 0.47 |
ENSG00000251908 |
. |
10753 |
0.22 |
chr3_143774434_143774585 | 0.47 |
C3orf58 |
chromosome 3 open reading frame 58 |
82059 |
0.11 |
chr22_45949176_45949470 | 0.47 |
FBLN1 |
fibulin 1 |
34660 |
0.15 |
chr11_4080418_4080569 | 0.47 |
STIM1 |
stromal interaction molecule 1 |
514 |
0.81 |
chr14_85786674_85786885 | 0.47 |
ENSG00000252529 |
. |
48503 |
0.2 |
chr15_42237434_42237585 | 0.47 |
CTD-2382E5.4 |
|
23894 |
0.1 |
chr6_150623249_150623400 | 0.47 |
ENSG00000201628 |
. |
24575 |
0.21 |
chr17_75281110_75281421 | 0.46 |
SEPT9 |
septin 9 |
2708 |
0.32 |
chr1_56046295_56046737 | 0.46 |
ENSG00000272051 |
. |
95871 |
0.09 |
chr7_133330724_133330997 | 0.46 |
EXOC4 |
exocyst complex component 4 |
69644 |
0.14 |
chr3_100118211_100119246 | 0.46 |
LNP1 |
leukemia NUP98 fusion partner 1 |
1309 |
0.37 |
chr18_43381353_43381623 | 0.46 |
SIGLEC15 |
sialic acid binding Ig-like lectin 15 |
23989 |
0.18 |
chr12_111178547_111179341 | 0.46 |
PPP1CC |
protein phosphatase 1, catalytic subunit, gamma isozyme |
1700 |
0.39 |
chr16_87469163_87469969 | 0.46 |
ZCCHC14 |
zinc finger, CCHC domain containing 14 |
2826 |
0.22 |
chr1_108559082_108559508 | 0.46 |
ENSG00000264753 |
. |
2098 |
0.38 |
chr7_20447658_20447906 | 0.46 |
ENSG00000200753 |
. |
30828 |
0.2 |
chr5_135347344_135347609 | 0.46 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
17108 |
0.2 |
chr14_100906069_100906661 | 0.46 |
RP11-362L22.1 |
|
33123 |
0.1 |
chr7_111726626_111727060 | 0.46 |
DOCK4 |
dedicator of cytokinesis 4 |
82657 |
0.1 |
chr2_120506867_120507018 | 0.45 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
10265 |
0.25 |
chr2_65605121_65605291 | 0.45 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
322 |
0.9 |
chr3_71592415_71592862 | 0.45 |
FOXP1 |
forkhead box P1 |
70 |
0.96 |
chr21_22572082_22572504 | 0.45 |
AP001136.2 |
|
26857 |
0.24 |
chr15_81604400_81605338 | 0.45 |
STARD5 |
StAR-related lipid transfer (START) domain containing 5 |
11597 |
0.18 |
chr12_45628891_45629097 | 0.45 |
ANO6 |
anoctamin 6 |
19091 |
0.27 |
chr3_24187776_24188063 | 0.45 |
THRB |
thyroid hormone receptor, beta |
19167 |
0.28 |
chr3_112964988_112965139 | 0.45 |
BOC |
BOC cell adhesion associated, oncogene regulated |
29865 |
0.18 |
chr9_37995152_37995751 | 0.45 |
ENSG00000251745 |
. |
58686 |
0.12 |
chr10_17714984_17715727 | 0.45 |
ENSG00000251959 |
. |
5832 |
0.17 |
chr18_46246557_46246844 | 0.45 |
RP11-426J5.2 |
|
31910 |
0.19 |
chr3_52865389_52865540 | 0.45 |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
709 |
0.49 |
chr2_105997925_105998220 | 0.45 |
AC012360.6 |
|
7522 |
0.19 |
chr5_57134689_57134840 | 0.44 |
ENSG00000266864 |
. |
34109 |
0.24 |
chr7_42284745_42284896 | 0.44 |
GLI3 |
GLI family zinc finger 3 |
8162 |
0.34 |
chr1_95257800_95258262 | 0.44 |
SLC44A3 |
solute carrier family 44, member 3 |
27867 |
0.18 |
chr8_79144122_79144471 | 0.44 |
ENSG00000252935 |
. |
166561 |
0.04 |
chr11_94483644_94484054 | 0.44 |
RP11-867G2.8 |
|
10328 |
0.22 |
chr3_174159594_174160082 | 0.44 |
NAALADL2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
1061 |
0.7 |
chr11_12088225_12088551 | 0.44 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
27155 |
0.22 |
chr7_157197915_157198509 | 0.44 |
DNAJB6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
65697 |
0.11 |
chr12_66088838_66088989 | 0.44 |
HMGA2 |
high mobility group AT-hook 2 |
128998 |
0.05 |
chr15_73900611_73900883 | 0.44 |
NPTN |
neuroplastin |
24357 |
0.22 |
chr9_21551182_21551333 | 0.44 |
MIR31HG |
MIR31 host gene (non-protein coding) |
8411 |
0.18 |
chr20_34323660_34324594 | 0.44 |
RBM39 |
RNA binding motif protein 39 |
4632 |
0.13 |
chr5_172226180_172226429 | 0.44 |
ENSG00000206741 |
. |
19207 |
0.13 |
chr11_72500407_72500904 | 0.44 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
3643 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 0.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.4 | 1.3 | GO:0010193 | response to ozone(GO:0010193) |
0.4 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.6 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.4 | 2.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 1.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.4 | 1.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 2.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 1.0 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 2.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 1.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.8 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.7 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.4 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 1.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.2 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.3 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.6 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.2 | 0.6 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 1.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.8 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 1.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 1.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 2.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.2 | 0.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.3 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.5 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.2 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.5 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.2 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.3 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.2 | 0.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 0.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.5 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.5 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 1.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.6 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 1.0 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 3.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 2.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 2.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.2 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0051284 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 2.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.4 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.4 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.3 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.1 | GO:0045986 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.4 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.4 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 1.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:1904063 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.1 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.4 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.6 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.5 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.6 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.1 | GO:0055026 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.4 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.1 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.6 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) male courtship behavior(GO:0008049) |
0.1 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:2000053 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.4 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.4 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.1 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.1 | 0.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0034766 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of ion transmembrane transport(GO:0034766) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.3 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 1.1 | GO:0051271 | negative regulation of cellular component movement(GO:0051271) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.3 | GO:0071450 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.2 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.2 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.5 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.1 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 1.6 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 1.8 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.6 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.3 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.9 | GO:0060606 | tube closure(GO:0060606) |
0.0 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0034969 | histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.8 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.6 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.5 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.0 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol(GO:0051279) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.3 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.0 | 0.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.3 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0007431 | salivary gland development(GO:0007431) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 1.5 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.2 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.2 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 1.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 0.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 1.9 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.8 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.5 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 2.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.0 | GO:0098644 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) complex of collagen trimers(GO:0098644) |
0.1 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.8 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 6.3 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 2.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 13.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 3.3 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 2.3 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 1.0 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 1.3 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 1.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.7 | GO:0097223 | acrosomal vesicle(GO:0001669) sperm part(GO:0097223) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.5 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 1.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 6.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 1.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 1.3 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.4 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 1.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 0.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.6 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.2 | 0.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.6 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.9 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 2.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 4.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 4.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.8 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.3 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 1.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 4.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 2.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.5 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 2.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.8 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 5.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 4.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 4.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 11.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 4.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 3.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 3.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 6.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 2.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.3 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |